GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRF) » Definitions » Shares Outstanding (Basic Average)

Starpharma Holdings (Starpharma Holdings) Shares Outstanding (Basic Average) : 410.87 Mil (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Starpharma Holdings Shares Outstanding (Basic Average)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Starpharma Holdings's average basic shares outstanding for the quarter that ended in Dec. 2023 was 410.87 Mil.


Starpharma Holdings Shares Outstanding (Basic Average) Historical Data

The historical data trend for Starpharma Holdings's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Shares Outstanding (Basic Average) Chart

Starpharma Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 371.29 372.23 396.88 406.90 409.04

Starpharma Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 406.32 407.48 408.59 409.48 410.87

Starpharma Holdings Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Starpharma Holdings  (OTCPK:SPHRF) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Starpharma Holdings Shares Outstanding (Basic Average) Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Shares Outstanding (Basic Average) provided by GuruFocus.com. Please click on the following links to see related term pages.


Starpharma Holdings (Starpharma Holdings) Business Description

Traded in Other Exchanges
Address
4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

Starpharma Holdings (Starpharma Holdings) Headlines

From GuruFocus

Starpharma creates slow release soluble DEP remdesivir nanoparticle

By Business Wire Business Wire 09-01-2020

Starpharma signs DEP� ADC Research Agreement with MSD

By PRNewswire PRNewswire 02-12-2021

Starpharma signs new DEP� agreement with MSD

By PRNewswire PRNewswire 08-10-2022

Starpharma's SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2

By Business Wire Business Wire 09-14-2020

Starpharma to present at OTCQX Virtual Investor Conference

By PRNewswire PRNewswire 04-11-2018

Starpharma SPL7013 Nasal Spray for COVID-19 – Development Update

By Business Wire Business Wire 08-25-2020

Starpharma's SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2

By Business Wire Business Wire 09-14-2020